A real-world study evaluating of existing treatments for patients with Atopic Dermatitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027071

Enrollment

Unknown

Registered

2019-10-30

Start date

2019-10-30

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

Case Series:According to the need

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. the age of 18 years of age or older, men and women not limited; 2. clinical signs and symptoms in patients diagnosed with atopic dermatitis; 3. outpatients.

Exclusion criteria

Exclusion criteria: Patients, who were pregnant, had autoimmune diseases, chronic systemic disease, and/or other skin diseases, or had a history of tumor or familial tumor diseases were excluded.

Design outcomes

Primary

Measure	Time frame
The Scoring Atopic Dermatitis (SCORAD) score;visual analogue scale (VAS);investigator's global assessment (IGA) score;dermatology life quality index (DLQI) score;	—

Countries

China

Contacts

Public ContactLi Linfeng

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University

zoonli@sina.com+86 13693620186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026